Last Updated 24.10.13
1.
Holmes MW, Goodacre S, Stevenson MD, Pandor A, Pickering A. The cost-effectiveness of
diagnostic management strategies for children with minor head injury. Arch Dis Child 2013
2.
Simpson EL, Stevenson MD, Scope A, Poku E, Minton J and Evans P. Echocardiography in newly
diagnosed atrial fibrillation patients: a systematic review and economic evaluation. Health
Technol Assess 2013; 17(36): 1-263
3.
Kearns BC, Michaels JA, Stevenson MD, Thomas S. Cost-effectiveness analysis of enhancements
to angioplasty for femoropopliteal arterial disease. British Journal Surgery 2013 100 (9): 11801188
4.
Tosh J, Archer R, Davis S, Stevenson M, Stevens JW. Golimumab for the Treatment of
Rheumatoid Arthritis After the Failure of Previous Disease-Modifying Antirheumatic Drugs: A
NICE Single Technology Appraisal. Pharmacoeconomics 2013 31(8): 653-661
5.
Tappenden P, Chilcott JB, Brennan A, Squires H, Stevenson M. Whole Disease Modelling to
inform resource allocation decisions in cancer: A methodological framework. Value in Health
2012 15 (8): 1127-36
6.
Hummel S, Stevenson M, Simpson E, Staffurth J. A Model of the Cost-effectiveness of Intensitymodulated Radiotherapy in Comparison with Three-dimensional Conformal Radiotherapy for the
Treatment of Localised Prostate Cancer. Clinical Oncology 2012 24 (10): e159-e167
7.
Whyte S, Pandor A, Stevenson M. Bevacizumab for Metastatic Colorectal Cancer: A NICE Single
Technology Appraisal. Pharmacoeconomics 2012; 30(12): 1119-1132
8.
Thokala P, Goodacre S, Collinson P, Stevens J, Mills N, Newby D, Morris F, Kendall J, Stevenson M.
“Cost-effectiveness of presentation and delayed troponin testing for acute myocardial infarction”
Heart 2012; 98: 1498-1503
9.
Holmes MW, Goodacre S, Stevenson MD, Pandor A, Pickering A. The cost-effectiveness of
diagnostic management strategies for adults with minor head injury. Injury 2012; 43 (9): 14231431
10.
Ara R, Pandor A, Stevens J, Rafia R, Ward SE, Rees A, Durrington PN, Reynolds TM, Wierzbicki AS,
Stevenson M. Prescribing high dose lipid-lowering therapy early to avoid subsequent
cardiovascular events - Is this a cost-effective strategy? European Journal of Cardiovascular
Prevention and Rehabilitation 2012 Jun; 19(3): 474-83
11.
Stevenson M, Lloyd Jones M, Morgan M, Wong R. The cost-effectiveness of non-invasive liver
tests in patients with suspected alcoholic liver disease. Health Technol Assess 2012; 16(4): 1-174
12.
Ara R, Blake L, Gray L, Hernández M, Crowther M, Dunkley A, Warren F, Jackson R, Rees A,
Stevenson M, Abrams K, Cooper N, Davies M, Khunti K, Sutton A. What is the clinical and costeffectiveness of using drugs in treating obese patients in primary care? Health Technol Assess
2012; 16(5): 1-202
13.
Bates SM, Jaeschke R, Stevens SM, Goodacre S, Wells PS, Stevenson MD, Kearon C, Schunemann
HJ, Crowther M, Pauker SG, Makdissi R, Guyatt GH. Diagnosis of DVT ACCP Evidence-Based
Clinical Practice Guidelines (Ninth Edition). Antithrombotic Therapy and Prevention of
Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice
Guidelines CHEST 2012; 141(2)(Suppl): e351S–e418S
14.
McKenna C, Maund E, Sarowar M, Fox D, Stevenson M, Pepper C, Woolacott N, Palmer S.
Dronedarone for the treatment of atrial fibrillation. A NICE Single Technology Appraisal.
Pharmacoeconomics 2012; 30(1): 35-46
15.
Cooper KL, Madan J, Whyte S, Stevenson MD, Akehurst R. Granulocyte colony-stimulating
factors for febrile neutropenia prophylaxis: systematic review and mixed treatment comparison.
BMC Cancer 2011, 11: 404
16.
Madan J, Stevenson MD, Ades T, Cooper KL, Whyte S, Akehurst R. Consistency between direct
trial evidence and Bayesian Mixed Treatment Comparison: Is head-to-head evidence always more
reliable? Value In Health 2011; 14(6): 953-960
17.
Carroll C, Stevenson M, Scope A, Evans P, Buckley S. Hemiarthroplasty and total-hip arthroplasty
for treating primary intracapsular fracture of the hip: A systematic review and cost effectiveness
analyses. Health Technol Assess 2011; 15(36): 1–74
18.
Pandor A, Goodacre S, Harnan S, Holmes M, Pickering A, Fitzgerald P, Rees A, Stevenson M.
Diagnostic management strategies for adults and children with minor head injury: a systematic
review and an economic evaluation. Health Technol Assess 2011; 15(27): 1–196
19.
Whyte S, Cooper KL, Stevenson MD, Madan J, Akehurst R. Cost-effectiveness of granulocyte
colony-stimulating factor prophylaxis for febrile neutropenia in breast cancer. Value in Health
2011; 14: 465-474
20.
Stevenson M, Pandor A. Febuxostat for the Management of Hyperuricaemia in Patients with
Gout. A NICE Single Technology Appraisal. Pharmacoeconomics 2011; 29,(2): 133-140
21.
Maund E, McKenna C , Sarowar M, Fox D, Stevenson M, Pepper C, Palmer S, Woolacott N.
Dronedarone for atrial fibrillation and atrial flutter. A Single Technology Appraisal. Health Technol
Assess 2010; 14(2): 55-62
22.
Stevenson MD Lloyd Jones M. The cost effectiveness of a randomized controlled trial to
establish the relative efficacy of vitamin K1 compared with alendronate. Medical Decision
Making 2011; (31): 43-52
23.
Hummel S, Simpson EL, Hemingway P, Stevenson MD, Rees A. Intensity-modulated radiotherapy
for the treatment of prostate cancer: a systematic review and economic evaluation. Health
Technol Assess 2010; 14 (47): 1-131
24.
Stevenson MD, Scope A, Sutcliffe PA, Booth A, Slade P, Parry G, Saxton D, Kaltenthaler E. Group
cognitive-behavioural therapy for postnatal depression: a systematic review of clinical and cost
effectiveness and value of information analyses. Health Technol Assess 2010; 14 (44): 1-107
25.
Stevenson MD, Scope A, Sutcliffe PA. The cost effectiveness of group cognitive behavioural
therapy compared with routine primary care for women with postnatal depression in the UK.
Value In Health 2010; 13(5): 580-584
26.
Stevenson MD, Simpson EL, Rawdin AC, Papaioannou DE. A review of discrete event simulation in
National Coordinating Centre for Health Technology Assessment funded work and a case study
exploring the cost-effectiveness of testing for thrombophilia in patients presenting with an initial
idiopathic venous thromboembolism. Journal of Simulation 2010; 4: 14-23
27.
Simpson E, Rafia R, Stevenson M, Papaioannou D. Single Technology Appraisal. Trabectedin for
the treatment of advanced metastatic soft tissue sarcoma. Health Technol Assess 2010; 14(1): 6367
28.
Madan J, Rawdin A, Stevenson M, Tappenden P. A rapid response economic evaluation of the UK
NHS Cancer Reform Strategy breast cancer screening programme extension via a plausible
bounds approach. Value In Health 2010; 13(2): 215-221
29.
Michaels JA, Campbell B, King BM, Palfreyman SJ, Shackley P, Stevenson MD. A prospective
randomised controlled trial and economic modelling of anti-microbial silver dressing bandages
versus non-adherent control dressings for venous leg ulcers: The Vulcan trial. Health Technol
Assess 2009; 13(56): 1 – 138
30.
Stevenson M, Lloyd Jones M, and Papaioannou D. Vitamin K to prevent fractures in older women:
systematic review and economic evaluation. Health Technol Assess 2009; 13(45): 1 – 134
31.
Stevenson MD, Oakley JE, Lloyd Jones M, Brennan A, Compston JE, McCloskey EV, Selby PL. The
cost-effectiveness of an RCT to establish whether 5 or 10 years of bisphosphonate treatment is
the better duration for women with a prior fracture. Medical Decision Making 2009; 29(6): 678689
32.
Stevenson M, Scope A, Holmes M, Rees A, Kalthenthaler E. Rivaroxaban for the treatment of
venous thromboembolism Health Technol Assess 2009; 13 (3): 43-48
33.
Stevenson M, Pandor A. Single Technology Apprasial - Febuxostat for the management of
hyperuricaemia in patients with gout. Health Technol Assess 2009; 13 (3): 37-42
34.
Wardlaw JM, Stevenson M, Chappell F, Rothwell PM, Gillard J, Young G, Thomas S, Roditi G,
Gough M. Carotid artery imaging for secondary stroke prevention: both imaging modality and
rapid access to imaging are important. Stroke 2009; 40(11): 3511-3517
35.
Stevenson MD, Macdonald FC, Langley J, Hunsche E, Akehurst RL. The cost-effectiveness of
bosentan in the UK for patients with pulmonary arterial hypertension of WHO functional class
III. Value in Health 2009; 12(8): 1100-1105
36.
Michaels JA, Campbell WB, King B, Palfreyman SJ, Shackley P, Stevenson M. A Randomised
Controlled Trial and Cost-effectiveness Analysis of Antimicrobial silver Antimicrobial Dressings for
Venous Leg Ulcers: The VULCAN Trial. British Journal of Surgery 2009; 96(10): 1147-1156
37.
Stevenson MD, Oakley JE, Chick SE, Chalkidou K. The cost-effectiveness of surgical instrument
management policies to reduce the risk of vCJD transmission to humans. Journal of Operational
Research Society 2009; 60: 506-518
38.
Simpson E, Stevenson M, Rawdin A, Papaioannou D. Thrombophilia Testing in people with
venous thromboembolism: systematic review and cost-effectiveness analysis. Health Technol
Assess 2009; 13 (2): 1 -144
39.
Sutton AJ, Cooper, NJ, Goodacre S, Stevenson M. Integration of meta-analysis and economic
decision modelling for evaluating diagnostic tests. Medical Decision Making 2008; 28: 650-667
40.
Ding H, Koinuma N, Stevenson M, Ito M, Monma Y. The cost-effectiveness of risedronate in
Japanese women with osteoporosis. Journal of Bone and Mineral Metabolism 2008; 26: 34-41
41.
Stevenson M, Davis S, Lloyd Jones M, Beverley C. The clinical and cost-effectiveness of
strontium ranelate for the prevention of osteoporotic fragility fractures in post-menopausal
women. Health Technol Assess 2007; 11 (4): 1-134
42.
Kanis JA, Stevenson M, McCloskey EV, Lloyd-Jones M, Davis S. Glucocorticosteroid Induced
Osteoporosis: A systematic review and cost-utility analysis. Health Technol Assess 2007; 11 (7): 1256
43.
O’Hagan A, Stevenson M, Madan J. Monte Carlo probabilistic sensitivity analysis for patient level
simulation models: Efficient estimation of mean and variance using ANOVA. Health Economics
2007; 16(10): 1009-23
44.
Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J et al. Accurate, practical
and cost-effective assessment of carotid stenosis in the UK. Health Technol Assess 2006; 10 (30):
1-200
45.
Stevenson MD, Davis SE, Kanis JA. The hospitalisation costs and out-patient costs of fragility
fractures. Women’s Health Medicine 2006; 3 (4): 149-151
46.
Goodacre S, Stevenson M, Wailoo A, Sampson F, Sutton AJ, Thomas S. How should we diagnose
suspected deep vein thrombosis? Q J Med 2006; 99: 377-388
47.
Goodacre S, Sampson F, Stevenson M, Wailoo A, Sutton A, Thomas S et al. Measurement of the
clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein
thrombosis. Health Technol Assess 2006; 10 (15): 1-168
48.
Stevenson M, Lloyd Jones M, De Nigris E, Brewer N, Davis S and Oakley J. A systematic review
and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for
the prevention and treatment of postmenopausal osteoporosis. Health Technol Assess 2005; 9
(22): 1-160
49.
Stevenson MD, Brazier JE, Calvert NW, Lloyd-Jones M, Oakley J, Kanis JA. Description of an
individual patient methodology for calculating the cost-effectiveness of treatments for
osteoporosis in women. Journal of Operational Research Society. 2005; 56 (2): 214-221
50.
Stevenson MD, Oakley J, Chilcott JB. Gaussian process modelling in conjunction with individual
patient simulation modelling. A case study describing the calculation of cost-effectiveness ratios
for the treatment of osteoporosis. Med Decis Making. 2004; 24: 89-100
51.
Stevenson MD, Beard SM, Finn A, Brennan A. Estimating the potential health gain and cost
consequences of introducing a pre-school pertussis booster into the UK child vaccination
schedule. Vaccine. 2002; 3052: 1-9
52.
Peters J, Stevenson M, Beverley C, Lim J, Smith S. A systematic and rapid review of the clinical and
cost-effectiveness of inhaler devices used in the routine management of chronic asthma in older
children. Health Technol Assess 2002; (6) No 5: 1- 167
53.
Kanis JA, Brazier J, Stevenson M, Lloyd-Jones M, Calvert NW. Treatment of Established
Osteoporosis. Health Technol Assess 2002; (6) No 29: 1 –1 46
54.
Stevenson MD, Oakley PA, Beard SM, Brennan A, Cook AL Triaging patients with serious head
injury: results of a simulation evaluating strategies to bypass hospitals without neurosurgical
facilities. Injury, Int. J. Care Injured 2001; (32): 267 – 274